Magnesium intake by enteral formulation affects serum magnesium concentration in patients undergoing hemodialysis
Magnesium intake by enteral formulation affects serum magnesium concentration in patients undergoing hemodialysis
复制标题
DOI：
10.1111/1744-9987.13760
复制
发表时间：
2021-11
影响因子：
1.9
通讯作者：
Kou Kitabayashi;Suguru Yamamoto;I. Narita
中科院分区：
文献类型：
--
作者：
Kou Kitabayashi;Suguru Yamamoto;I. Narita
血清镁水平降低与慢性肾病患者的死亡率和骨折有关；然而，对这些人群的镁摄入量并没有建议。本研究采用横断面分析来检验血液透析患者镁摄入量与血清镁水平之间的关系。纳入61例患者。日Mg摄入量为185 Mg (IQR: 151 ~ 203 Mg)，血清Mg水平为2.4 Mg /dL （IQR: 2.2 ~ 2.7 Mg /dL）。多元回归分析显示，管饲肠内制剂的摄入是影响血清Mg水平的独立因素（B = 0.90[95%可信区间：0.61 ~ 1.20],p < 0.01）。这些发现可能有助于血液透析患者通过饮食和肠内制剂来管理血清Mg水平。
Decreased serum magnesium levels are associated with mortality and fractures in patients with chronic kidney disease; however, there is no recommendation for Mg intake in these populations. This study used cross‐sectional analysis to examine the association between Mg intake and serum Mg levels in patients undergoing hemodialysis. Sixty‐one patients were included. The daily Mg intake was 185 mg (IQR: 151–203 mg), and serum Mg level was 2.4 mg/dL (IQR: 2.2–2.7 mg/dL). Multiple regression analysis showed that intake of enteral formulation by tube feeding was an independent factor associated with serum Mg level (B = 0.90 [95% confidence interval: 0.61–1.20], p < 0.01). These findings may aid in serum Mg level management through diet and enteral formulation in patients undergoing hemodialysis.